Thrombopoietin Agonists for the Treatment of Thrombocytopenia in Liver Disease and Hepatitis C
- 31 August 2009
- journal article
- review article
- Published by Elsevier in Clinics in Liver Disease
- Vol. 13 (3) , 487-501
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Discovery and biological evaluation of benzo[a]carbazole-based small molecule agonists of the thrombopoietin (Tpo) receptorBioorganic & Medicinal Chemistry Letters, 2008
- Optimization of small molecule agonists of the thrombopoietin (Tpo) receptor derived from a benzo[a]carbazole hit scaffoldBioorganic & Medicinal Chemistry Letters, 2008
- The effect of a novel, small non-peptidyl molecule butyzamide on human thrombopoietin receptor and megakaryopoiesisHaematologica, 2008
- Thrombocytopenia in liver diseaseCurrent Opinion in Hematology, 2008
- Historical review: megakaryopoiesis and thrombopoiesisBlood, 2008
- Thrombopoietin Mimetic Agents in the Management of Immune Thrombocytopenic PurpuraSeminars in Hematology, 2007
- Current Options for the Treatment of Idiopathic Thrombocytopenic PurpuraSeminars in Hematology, 2007
- Partial splenic embolization facilitates completion of interferon therapy in patients with chronic HCV infection and hypersplenismJournal of Gastroenterology, 2005
- Partial Splenic Embolization for the Treatment of Hypersplenism in Liver Transplanted Patients with Hepatitis C Virus Recurrence before peg-Interferon Plus RibavirinTransplantation, 2005
- Peptide Agonist of the Thrombopoietin Receptor as Potent as the Natural CytokineScience, 1997